| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 8.651 | 15.032 | 16.406 | 16.527 | 16.304 | 13.546 | 11.020 | 12.862 |
| Total Income - EUR | - | - | 8.651 | 15.032 | 16.406 | 17.510 | 21.415 | 15.508 | 11.020 | 12.862 |
| Total Expenses - EUR | - | - | 6.516 | 10.487 | 9.946 | 15.640 | 16.800 | 11.632 | 8.073 | 10.367 |
| Gross Profit/Loss - EUR | - | - | 2.135 | 4.544 | 6.460 | 1.870 | 4.616 | 3.876 | 2.946 | 2.495 |
| Net Profit/Loss - EUR | - | - | 1.878 | 4.093 | 6.045 | 1.772 | 4.574 | 3.476 | 2.492 | 2.068 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 |
Check the financial reports for the company - Anavir S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 1.110 | 933 | 557 | 232 | 1.579 | 1.399 |
| Current Assets | - | - | 11.357 | 9.842 | 10.954 | 13.406 | 17.690 | 8.980 | 14.003 | 14.191 |
| Inventories | - | - | 10.131 | 9.418 | 9.165 | 8.841 | 9.393 | 8.909 | 12.727 | 11.190 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | 1.225 | 424 | 1.789 | 4.565 | 8.297 | 72 | 1.277 | 3.001 |
| Shareholders Funds | - | - | 1.922 | 5.979 | 11.908 | 13.454 | 17.730 | 8.454 | 10.978 | 12.984 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 9.435 | 3.863 | 155 | 885 | 517 | 759 | 4.604 | 2.606 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4712 - 4712" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Anavir S.r.l.